In breast cancer, a strong infiltration with CD8+ cytotoxic T lymphocytes has been reported to be associated with a favorable response to neoadjuvant chemotherapy and good clinical outcome in breast cancer [15–17]. Here, CD8A is linked to breast carcinoma.